论文部分内容阅读
目的探讨乳果糖预防肝性脑病的疗效。方法选择2006年6月至2010的6月确诊的肝硬化患者62例,对照组给予肌苷和维生素B,治疗组加用乳果糖口服。48周后观察两组HE、SHE发病情况。结果治疗组HE和SHE发病率显著低于对照组,差异有统计学意义(P<0.05)。结论肝硬化患者间断或长期服用乳果糖可显著降低肝性脑病的发病率。
Objective To investigate the efficacy of lactulose in prevention of hepatic encephalopathy. Methods Sixty-two patients with cirrhosis confirmed in June 2006 to June 2010 were treated with inosine and vitamin B in the control group and lactulose in the treatment group. After 48 weeks, the incidence of HE and SHE in both groups was observed. Results The incidence of HE and SHE in the treatment group was significantly lower than that in the control group (P <0.05). Conclusion Intermittent or long-term use of lactulose in patients with cirrhosis can significantly reduce the incidence of hepatic encephalopathy.